📣 Try out the NEW Gateway to Research and let us know what you think.

We're looking for users to test the new service during August and September and share their feedback. Express your interest by completing this short form.

Tumour cell responses to new fibroblast growth factor receptor tyrosine kinase inhibitors and identification of a gatekeeper mutation in FGFR3 as a mechanism of acquired resistance. (2013)

First Author: Chell V

Attributed to: Molecular basis of NADPH oxidase activation funded by BBSRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1038/onc.2012.319

PubMed Identifier: 22869148

Publication URI: http://europepmc.org/abstract/MED/22869148

Type: Journal Article/Review

Volume: 32

Parent Publication: Oncogene

Issue: 25

ISSN: 0950-9232